Report overview
Staphylococcal infections are usually caused by the organism Staphylococcus aureus.
This report contains market size and forecasts of Staphylococcal Infection Drugs in global, including the following market information:
Global Staphylococcal Infection Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Staphylococcal Infection Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Staphylococcal Infection Drugs companies in 2021 (%)
The global Staphylococcal Infection Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Beta-lactams Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Staphylococcal Infection Drugs include Allergan, Bayer, GlaxoSmithKline, Merck and Pfizer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Staphylococcal Infection Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Staphylococcal Infection Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Staphylococcal Infection Drugs Market Segment Percentages, by Type, 2021 (%)
Beta-lactams
Peptides
Quinolones
Others
Global Staphylococcal Infection Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Staphylococcal Infection Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Pharmacy
Other
Global Staphylococcal Infection Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Staphylococcal Infection Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Staphylococcal Infection Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Staphylococcal Infection Drugs revenues share in global market, 2021 (%)
Key companies Staphylococcal Infection Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Staphylococcal Infection Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Bayer
GlaxoSmithKline
Merck
Pfizer
